DOVER, Del., June 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company formed under the laws of the British Virgin Islands (“Portage”), announced today that on June 24, 2025, the Company received formal notice from The Nasdaq Stock Market LLC that the Company has evidenced compliance with all applicable requirements for continued listing on The Nasdaq Capital Market. About Portage BiotechPortage Biotech is a clinical-stage im ...

TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Reported quarterly adjusted diluted earnings per share of $0.39 Total assets under management and fee-earning assets of $53.5 billion Declared quarterly dividend per share to 12.5 cents AGF Management Limited (AGF or the Company) (TSX: AGF.B) today announced financial results for the second quarter ended May 31, 2025. "Through a challenging environment, we experienced our fourth consecutive quarter of positive retail mutual fund and mutual fund net sales outpacing ...

TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- On June 24, 2025, the Board of Directors of AGF Management Limited declared a dividend of 12.5 cents per share on both the Class B Non-Voting shares and the Class A Voting common shares of the company. This dividend will be payable on July 17, 2025 to shareholders of record on July 3, 2025. Headquartered in Toronto, Canada, AGF has investment operations and client servicing teams on the ground in North America and Europe. With over $53 billion in total assets under ...

Boralex unveiled its most recent Corporate Social Responsibility (CSR) Report last February. Among the highlights for the year, the Company reviewed its talent acquisition process for inclusive recruitment, won the 'Workforce Development' award at Nergica's Reconnaissance renewable energy gala for its wind maintenance training program for Innus and obtained approval of its greenhouse gas emission reduction targets from the Science-based Target Initiative (SBTi). More details on Boralex's CSR strategy are av ...

TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Nobel Resources Corp. (TSX – V: NBLC) (the “Company” or “Nobel”) is pleased to provide an update on progress at its Cuprita Project (the “Project” or “Cuprita”) in Atacama Region, Chile. Nobel geologists have identified a leach cap at Cuprita with an associated copper, lead and zinc anomaly in soils. The leach cap and soil anomaly are located adjacent to a ground magnetic low and are situated near the intersection of a major north-northeast striking fault structure ...

VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) -- ExGen Resources Inc. (TSX.V: EXG; OTC: BXXRF) ("ExGen", the "Company"): ExGen is pleased to provide an update in respect of Phoenix Copper Limited's ("Phoenix") development and construction activities at the Empire Mine Project in Custer County, Idaho, USA, further to Phoenix's news release of June 12, 2025. ExGen owns 20% and Phoenix owns 80% of Konnex Resources, Inc. ("Konnex"), which holds the leases and claims to the Empire Mine Project, whi ...

TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Matador Technologies Inc. (“Matador” or the “Company”) (TSXV: MATA, OTCQB: MATAF, FSE: IU3) announces that the Company has acquired an additional 8.4 bitcoin for CAD$1.2M (USD$878,763). The 8.4 bitcoin was acquired at an average price of USD$104,914 per bitcoin, inclusive of fees and expenses. The purchase was made following a recent market correction, in line with the Company’s Bitcoin acquisition policy, further reinforcing its conviction in Bitcoin as a long-ter ...

MONTREAL, June 25, 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG; OTCQX: CHXMF; FSE: CM5R) is pleased to announce that it has officially filed the Environmental and Social Impact Assessment (“ESIA”) for its flagship Troilus Copper-Gold Project (“Troilus” or the “Project”) with both the Government of Québec, via the Ministère de l’Environnement, de la Lutte contre les changements climatiques, de la Faune et des Parcs (“MELCCFP”), and the Government of Canada, via the Impac ...

文章核心观点 - Iterum Therapeutics公司的REASSURE 3期临床试验结果在NEJM Evidence发表，口服舒洛培南在治疗成年女性单纯性尿路感染（uUTI）上非劣于阿莫西林/克拉维酸，且显示出优越性，公司预计ORLYNVAH™下个季度可用于治疗难治性感染女性患者 [1][2][4] 公司情况 - Iterum Therapeutics专注于提供下一代口服和静脉注射抗生素，以治疗社区和医院环境中由多重耐药病原体引起的感染，正在推进其首个化合物舒洛培南的开发，有口服和静脉注射两种剂型 [1][9] - 公司的ORLYNVAH™（口服舒洛培南）已获FDA批准，用于治疗由指定微生物引起的、成年女性有限或无替代口服抗菌治疗选择的单纯性尿路感染，其口服和静脉注射剂型的舒洛培南在七个适应症中获得合格传染病产品（QIDP）和快速通道指定 [5][9] 临床试验情况 - REASSURE试验是一项非劣效性试验，比较口服舒洛培南和阿莫西林/克拉维酸在阿莫西林/克拉维酸敏感人群中的疗效，试验招募2222名患者，在与FDA的SPA协议下进行 [2] - 主要人群中9.2%的患者基线病原体对三类或更多类抗生素耐药 [3] - 结果显示，在微生物改良意向治疗敏感（m - MITTS）人群的治愈测试（TOC）访视中，口服舒洛培南在主要终点总体反应上非劣于阿莫西林/克拉维酸，且显示出统计学上的优越性，口服舒洛培南患者总体成功率为61.7%，阿莫西林/克拉维酸为55.0% [4] 产品情况 - ORLYNVAH™是一种新型口服青霉烯类抗生素，对肠杆菌科细菌具有强效活性，包括那些编码超广谱β - 内酰胺酶（ESBL）或AmpC型β - 内酰胺酶、对第三代头孢菌素具有耐药性的细菌 [10] 行业情况 - 尿路感染是社区中最常见的细菌感染之一，美国每年约有1500万急诊和门诊就诊，超过4000万份单纯性尿路感染处方，约三分之二（2600万）处方针对治疗失败风险较高的患者 [7] - 美国约30%的单纯性尿路感染由喹诺酮非敏感病原体引起，约1%的感染由对所有常用口服抗生素类耐药的病原体引起，病原体耐药性发展使尿路感染治疗更具挑战性，一半女性一生中至少经历一次单纯性尿路感染 [7]

Delivered close to 1,300 vehicles1Total revenue reached $93 millionGross margin was 12% as the impact from prior destocking efforts easedThe operating loss in the first quarter narrowed by more than 50% year-on-year to $103 million NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Lotus Technology Inc. (“Lotus Tech” or the “Company”), a leading global intelligent and luxury mobility provider, today announced its unaudited financial results for the first quarter ended March 31, 2025. Operating Highlights for the F ...